Drawing for DAPAVIR

USPTO serial 77500604

DAPAVIR

Reviewed by CopyMark Law Group

Reg. 3702756Status 710
Filing date
Status date
Registration date
Oct 27, 2009
Examiner
YAO, GRETTA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with DAPAVIR?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

David Bradin

DAVID BRADIN IPTLPO BOX 14329RESEARCH TRIANGLE PARK, NC 27709-4329UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Antivirals; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancerSECTION 8 - CANCELLEDJul 20, 2009

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 3, 2016C8..CANCELLED SEC. 8 (6-YR)—
Oct 27, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 18, 2009REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Sep 9, 2009CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 1, 2009SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Sep 1, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Aug 3, 2009IUAFUSE AMENDMENT FILED—
Aug 3, 2009EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 3, 2009NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 11, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 22, 2008NPUBNOTICE OF PUBLICATION—
Oct 6, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Oct 6, 2008ALIEASSIGNED TO LIE—
Sep 24, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 23, 2008DOCKASSIGNED TO EXAMINER—
Jun 20, 2008NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance